Table 5. Prediction performance for 3-month treatment outcomes. Parentheses denote standard deviations in cross validation.
Target | Model | Validation BS | Testing BS |
---|---|---|---|
<6.5% | RF | 0.2294 (0.0256) | 0.1634 |
GBT | 0.1684 (0.0198) | 0.1430 | |
TPGE | 0.1315 (0.0025) | 0.1389 | |
<7.0% | RF | 0.1949 (0.0237) | 0.1939 |
GBT | 0.1961 (0.0243) | 0.1616 | |
TPGE | 0.1437 (0.0032) | 0.1576 | |
<7.5% | RF | 0.2741 (0.0569) | 0.1682 |
GBT | 0.1727 (0.0067) | 0.1448 | |
TPGE | 0.1319 (0.0027) | 0.1405 | |
<8.0% | RF | 0.2197 (0.0828) | 0.1307 |
GBT | 0.1317 (0.0102) | 0.1121 | |
TPGE | 0.1059 (0.0022) | 0.1098 | |
<8.5% | RF | 0.0944 (0.0040) | 0.1030 |
GBT | 0.0945 (0.0040) | 0.0854 | |
TPGE | 0.0809 (0.0018) | 0.0850 | |
Average | RF | 0.2025 (0.0386) | 0.1518 |
GBT | 0.1527 (0.0130) | 0.1294 | |
TPGE | 0.1188 (0.0025) | 0.1264 |
Abbreviations: BS, Brier Score; GBT, Gradient Boosting Tree; RF, Random Forest; TPGE, Treatment Pathway Graph-based Estimation.